Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction

Japanese Journal of Pharmacology

Volumn 80, Issue 1, 1999, Pages 41-48

  Satoh, Shin ichi ^a   Kobayashi, Teruki ^a   Hitomi, Asako ^a   Ikegaki, Ichiro ^a   Suzuki, Yoshio ^b   Shibuya, Masato ^c   Yoshida, Jun ^b   Asano, Toshio ^a  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHUKYO HOSPITAL   (Japan)

Author keywords

Cerebral ischemia; Fasudil; Migration; Neutrophil; Protein kinase inhibitor

Indexed keywords

COMPLEMENT COMPONENT C5A; DRUG METABOLITE; FASUDIL; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MYELOPEROXIDASE; MYOSIN LIGHT CHAIN KINASE; OZAGREL; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MICROEMBOLISM; MIGRATION INHIBITION; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; RAT;

EID: 0033011472     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.80.41     Document Type: Article

References (38)

1. Fujinuma K, Kitai N, Sakai S, Iizuka T and Kanda T: In-111-labeled leukocyte brain SPECT imaging in acute embolic stroke in man. J Cereb Blood Flow Metab 15, Suppl 1, S679 (1995)
2. Akopov SE, Simonian NA and Grigorian GS: Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 27, 1739-1743 (1996)
3. Jiang N, Moyle M, Soule HR, Rote WE and Chopp M: Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann Neurol 38, 935-942 (1995)
4. Jiang N, Chopp M and Chahwala S: Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Res 788, 25-34 (1998)
5. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM and Anderson DC: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26, 1438-1443 (1995)
6. Connolly ES, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stern DM, Solomon RA, Gutierrez-Ramos J-C and Pinsky DJ: Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 97, 209-216 (1996)
7. Mackay KB, Bailey SJ, King PD, Patel S, Hamilton TC and Campbell CA: Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat. Neurodegeneration 5, 319-323 (1996)
8. Heuertz RM, Ahmed N and Webster RO: Peptides derived from C-reactive protein inhibit neutrophil alveolitis. J Immunol 156, 3412-3417 (1996)
9. Allport JR, Donnelly LE, Hayes BP, Murray S, Rendell NB, Ray KP and MacDermot J: Reduction by inhibitors of mono (ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin. Br J Pharmacol 118, 1111-1118 (1996)
10. Bittleman DB, Erger RA and Casale TB: Cytokines induce selective granulocyte chemotactic responses. Inflamm Res 45, 89-95 (1996)
11. Kuroki M and O'Flaherty JT: Differential effects of a mitogen-activated protein kinase kinase inhibitor on human neutrophil responses to chemotactic factors. Biochem Biophys Res Commun 232, 474-477 (1997)
12. Nick JA, Avdi NJ, Young SK, Knall C, Gerwins P, Johnson GL and Worthen GS: Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and fMLP. J Clin Invest 99, 975-986 (1997)
13. Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M and Hidaka H: Mechanism of action of a novel anti-vasospasm drug, HA1077. J Pharmacol Exp Ther 241, 1033-1040 (1987)
14. 2+ antagonist and vasodilator, on chronic cerebral vasospasm. Eur J Pharmacol 220, 243-248 (1992)
15. Satoh S, Yamamoto Y, Toshima Y, Ikegaki I, Asano T, Suzuki Y and Shibuya M: Fasudil, a protein kinase inhibitor, prevents the development of endothelial injury and neutrophil infiltration in a two-haemorrhage canine model. J Clin Neurosci (in press)
16. Toshima Y, Satoh S, Ikegaki I, Asano T, Suzuki Y and Shibuya M: Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm. Life Sci 61, 1371-1377 (1997)
17. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, Suzuki Y and Hidaka H: Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98, 1091-1100 (1989)
18. Seto M, Shindo K, Ito K and Sasaki Y: Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077. Eur J Pharmacol 276, 27-33 (1995)
19. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M and Narumiya S: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994 (1997)
20. Asano T, Ikegaki I, Satoh S, Mochizuki D, Hidaka H, Suzuki Y, Shibuya M and Sugita K: Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain. Br J Pharmacol 103, 1935-1938 (1991)
21. Ohtaki M and Tranmer B: Pretreatment of transient focal cerebral ischemia in rats with the calcium antagonist AT877. Stroke 25, 1234-1240 (1994)
22. Satoh S, Suzuki Y, Ikegaki I, Asano T, Shibuya M, Sugita K and Hidaka H: The effects of HA1077 on the cerebral circulation after subarachnoid haemorrhage in dogs. Acta Neurochir 110, 185-188 (1991)
23. Tsuchiya M, Sako K, Yonemasu Y and Asano T: The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats. Exp Brain Res 97, 233-238 (1993)
24. Maiese K, Wagner J and Boccone L: Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade. Neurosci Lett 166, 43-47 (1994)
25. Arai M, Sasaki Y and Nozawa R: Inhibition by the protein kinase inhibitor HA1077 of the activation of NADPH oxidase in human neutrophils. Biochem Pharmacol 46, 1487-1490 (1993)
26. Satoh S, Ikegaki I, Suzuki Y, Asano T, Shibuya M and Hidaka H: Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils. Br J Pharmacol 118, 1592-1596 (1996)
27. Seto M, Sasaki Y and Sasaki Y: Alteration in the myosin phosphorylation pattern of smooth muscle by phorbol ester. Am J Physiol 259, C769-C774 (1990)
28. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H and Nakashima M: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 78, 571-577 (1992)
29. Adelstein RS: Regulation of contractile proteins by phosphorylation. J Clin Invest 72, 1863-1866 (1983)
30. Janeczek AH, Van-Alten PJ, Reyes HM and Walter RJ: Modulation of the cytoskeleton and intracellular calcium in leukocytes exhibiting a cancer-associated chemotaxis defect. J Leukoc Biol 54, 351-359 (1993)
31. Downey GP, Chan CK, Lea P, Takai A and Grinstein S: Phorbol ester-induced actin assembly in neutrophils: role of protein kinase C. J Cell Biol 116, 695-706 (1992)
32. Kreienbuhl P, Keller H and Niggli V: Protein phosphatase inhibitors okadaic acid and calyculin A alter cell shape and F-actin distribution and inhibit stimulus-dependent increases in cytoskeletal actin of human neutrophils. Blood 80, 2911-2919 (1992)
33. Dang PM-C, Rais S, Hakim J and Perianin A: Redistribution of protein kinase C isoforms in human neutrophils stimulated by formyl peptides and phorbol myristate acetate. Biochem Biophys Res Commun 212, 664-672 (1995)
34. 175 in porcine coronary artery. Eur J Pharmacol 360, 257-264 (1998)
35. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T and Kogure K: Correlation between myeloper-oxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25, 1469-1475 (1994)
36. Brian S and Marc F: Trends in protecting ischemic brain. In Acute Stroke Treatment, Edited by Julien B, pp 149-162, Martin Dunitz, London (1997)
37. Beley A, Edvinsson L and Hardebo JE: Cerebral microembolization in rat: Changes in blood-brain barrier permeability and cerebral blood flow as related to the degree of ischemia. Acta Neurol Scand 64, 88-100 (1981)
38. 2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046). Jpn J Pharmacol 41, 393-401 (1986)